KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Elanco Animal Health (ELAN) Short-term Investments (2018 - 2020)

Elanco Animal Health (ELAN) has disclosed Short-term Investments for 3 consecutive years, with $11.0 million as the latest value for Q4 2020.

  • Quarterly Short-term Investments changed 0.0% to $11.0 million in Q4 2020 from the year-ago period, while the trailing twelve-month figure was $11.0 million through Dec 2020, changed 0.0% year-over-year, with the annual reading at $11.0 million for FY2020, 0.0% changed from the prior year.
  • Short-term Investments hit $11.0 million in Q4 2020 for Elanco Animal Health, roughly flat from $11.0 million in the prior quarter.
  • In the past five years, Short-term Investments ranged from a high of $634.9 million in Q3 2018 to a low of $11.0 million in Q4 2019.
  • Historically, Short-term Investments has averaged $94.4 million across 3 years, with a median of $11.0 million in 2019.
  • Biggest five-year swings in Short-term Investments: tumbled 98.25% in 2019 and later changed 0.0% in 2020.
  • Year by year, Short-term Investments stood at $202.7 million in 2018, then crashed by 94.57% to $11.0 million in 2019, then changed by 0.0% to $11.0 million in 2020.
  • Business Quant data shows Short-term Investments for ELAN at $11.0 million in Q4 2020, $11.0 million in Q3 2020, and $11.0 million in Q2 2020.